| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | President And CEO | CEO And President
3 companies
Erck Stanley C is a Director at MXCT with holdings across 3 companies. Recent SEC Form 4 filings include 6 buys and 2 sells.
Estimated insider holdings value: $1.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 14, 2018 | NVAX Novavax Inc | President And CEO | Buy | 100,000 | $1.65 | $164,620.00 | +43.8% | |
| Nov 9, 2017 | NVAX Novavax Inc | President And CEO | Buy | 100,000 | $1.13 | $113,050.00 | +78.0% | |
| May 11, 2017 | NVAX Novavax Inc | President And CEO | Buy | 50,000 | $0.84 | $41,980.00 | +63.9% | |
| Mar 31, 2016 | NVAX Novavax Inc | President And CEO | Sale+OE | 424,778 | $5.19 | $2,203,619.18 | -70.1% | |
| Jan 31, 2016 | NVAX Novavax Inc | CEO And President | Buy | 2,072 | $4.38 | $9,075.36 | +2.1% | |
| Jul 31, 2015 | NVAX Novavax Inc | CEO And President | Buy | 3,207 | $2.28 | $7,311.96 | +3.3% | |
| Jan 31, 2015 | NVAX Novavax Inc | CEO And President | Buy | 6,122 | $2.28 | $13,958.16 | +6.7% |